Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)-Reference-Cited by-同舟云学术

Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)

Published:2022-07-05 Issue:3 Volume:61 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Li Sui¹,Xie Xiaofang²,Peng Fu¹,Du Junrong¹,Peng Cheng²

Affiliation:

1. Department of Pharmacology, Key Laboratory of Drug‑Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant‑Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, P.R. China

2. State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 611137, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference158 articles.

1. The 2016 World Health Organization classification of tumors of the central nervous system: A summary;Louis;Acta Neuropathol,2016

2. Non-coding RNAs in glioma;Rynkeviciene;Cancers (Basel),2018

3. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme;De Sanctis;Anticancer Drugs,2006

4. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial;Stupp;JAMA,2017

5. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines;2024-06-17

2. Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives;CNS Neuroscience & Therapeutics;2024-05

3. CREB-induced LINC00473 promotes chemoresistance to TMZ in glioblastoma by regulating O6-methylguanine-DNA-methyltransferase expression via CEBPα binding;Neuropharmacology;2024-02

4. Clinical implications of lncRNA LINC-PINT in cancer;Frontiers in Molecular Biosciences;2023-03-17

5. VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization;International Journal of Oncology;2023-01-30